Développement galénique et analytique d'un collyre à base de tacrolimus 0,06 %

3Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose: The administration of topical tacrolimus (FK506) eye drops or ointment is effective in treating certain immunologic corneal diseases and in the prevention of rejection of high-risk corneal grafts. The purpose of this study is to determine the optimal formulation of tacrolimus 0.06% eye drops. A procedure for preparation is presented and discussed. Methods: Tacrolimus monohydrate powder and virgin castor oil are used in this new formulation. The manufacturing process guarantees consistency of product sterility. Measurement by high-performance liquid chromatography allows precise control of the concentration of tacrolimus. Results: The manufacture and packaging of tacrolimus 0.06% eye drops involve numerous controls allowing for guaranteed sterility and stability. The drops remained sterile and stabile for 28 days after opening regardless of storage conditions and can be stored for 3 months after manufacture. Tolerability studies are currently being performed. © 2013 Elsevier Masson SAS. All rights reserved.

Cite

CITATION STYLE

APA

Gauthier, A. S., Rival, B., Sahler, J., Fagnoni-Legat, C., Limat, S., Guillaume, Y., & Delbosc, B. (2013). Développement galénique et analytique d’un collyre à base de tacrolimus 0,06 %. Journal Francais d’Ophtalmologie, 36(5), 408–413. https://doi.org/10.1016/j.jfo.2012.03.019

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free